Pharmacokinetics of enrofloxacin in sturgeon Acipenser schrenckii

GUO Jiao-jiao,PAN Hong-yan,YANG Hu,LIAO Xin,GONG Zhi-yong,LI Gu
DOI: https://doi.org/10.3969/j.issn.1000-9957.2011.04.015
2011-01-01
Abstract:The pharmacokinetics of enrofloxacin in the sturgeon Acipenser schrenckii administrated by oral gavage at a dos of 10 mg/kg was investigated using the HPLC and by pharmacokinetics software 3P97.The concentrations versus time in plasma,muscle and liver in the sturgeon were well described by a two-department open model with first-order absorption,with the average enrofloxacin recovery of 93.6%±1.14% in plasma,92.65%±1.5% in muscle,and 92.82%±1.39% in liver.The enrofloxacin in the sturgeon had the ability to be widely distributed to diverse tissues.The apparent volume of distribution was found to be 26.987 L/kg in the plasma,6.2298 L/kg in the muscle and 2.1515 L/kg in the liver.The enrofloxacin elimination was found slowly,the elimination half-life(T1/2β) of 290.139 h in the plasma,114.9 h in the muscle and 901.835 h in the liver,and the total body clearance(CL/f(s)) of 0.2288 L/(kg·h) in the plasma,0.1047 L/(kg·h) in the muscle and 0.02164 L/(kg·h) in the liver.So we suggest that other antibacterial drugs be used to prevent and treat bacterial diseases in the process of sturgeon growth on.
What problem does this paper attempt to address?